Commercial Market: Boston, MA (2024)

Executive Summary

Vacancy Rates:

Office: 15.0% (down from 16.5% in 2023).

Lab Space: 10.2% (up slightly due to new supply).

Retail: 8.7% (reviving post-pandemic).

Rent Trends:

Lab space: $125/sq. ft. (+7% YoY).

Class A office: $68/sq. ft. (+3% YoY).

Industrial: $18/sq. ft. (+10% YoY).

Investment Volume: $4.2B YTD (down 18% YoY due to interest rates).

Top 5 Emerging Submarkets

Allston/Brighton

Catalyst: Harvard’s $1B Enterprise Research Campus.

Key Projects:

160 Lincoln Street: 350K sq. ft. lab/office (2025 delivery).

Boston Landing Expansion: 500K sq. ft. mixed-use.

Rent Premium: Lab spaces command 20% over Cambridge.

Dorchester (South Bay)

Catalyst: $4B South Bay redevelopment.

Pipeline:

South Bay Town Center: 2M sq. ft. retail/office.

1,200 residential units (40% affordable).

Roxbury (Nubian Square)

Catalyst: $500M city-led revitalization plan.

Projects:

Bromley-Heath Redevelopment: 2,100 mixed-income units.

Nubian Square Arts District: 150K sq. ft. creative office space.

Suffolk Downs (East Boston)

Catalyst: 16M sq. ft. mega-development (labs, housing, retail).

Investors: HYM Investment Group, National Grid.

Cambridge (Kendall Square Expansion)

Catalyst: MIT’s tech spillover.

Pipeline:

25-35 Binney Street: 900K sq. ft. lab space.

Volpe Center Redevelopment: 1.4M sq. ft. mixed-use.

Major Active Developments
Project Location Size Investment Status
Suffolk Downs East Boston 16M sq. ft. $8B+ Phase 1 (2025)
South Station Tower Downtown 800K sq. ft. $1.3B Topped Out (2024)
1000 Boylston Back Bay 1M sq. ft. $800M 60% Leased
The St. Regis Residences Seaport 114 units $500M Sold Out (2024)
Fenway Center Fenway 1.3M sq. ft. $950M Phase 2 Underway
NBA Stadium Site Analysis

The Boston Celtics’ TD Garden lease expires in 2029. Three leading sites for a new arena:
1. Suffolk Downs (East Boston)

Pros:

161-acre site with Blue Line/MBTA access.

Minimal residential opposition (vs. downtown).

Cons:

Requires rezoning from industrial to mixed-use.

Competing lab developers (e.g., BioMed Realty).

2. Widett Circle (South Boston)

Pros:

Proximity to downtown (2 miles).

I-93/I-90 highway access.

Cons:

Limited land (would require raiding industrial sites).

Flood risk (Climate Ready Boston maps).

3. TD Garden Renovation

Fallback Plan: $300M upgrade to existing site.

Features: Expanded concourse, tech upgrades, retail.

Market Segmentation
Office/Life Sciences

Lab Space Dominance:

70% of new construction is lab-enabled.

Vacancy expected to rise to 12% by 2025 (4M sq. ft. new supply).

Office Conversions:

2M sq. ft. of outdated offices being converted to labs (e.g., 2 Center Plaza).

Retail

Revival Hotspots:

Seaport: 40 new stores in 2024 (e.g., Apple, RH).

Newbury Street: Luxury leasing at $300/sq. ft.

Challenges:

Downtown retail vacancy remains at 12% (down from 18% in 2021).

Industrial/Logistics

Last-Mile Demand:

Vacancy at 4.2% (lowest in Northeast).

Rents up 8% YoY to $18/sq. ft.

Key Corridors:

I-93 North (Chelsea, Everett).

Route 128 West (Needham, Waltham).

Multifamily

Rent Growth:

Luxury units: $3,800/month (+5% YoY).

Affordable units: 10,000 in pipeline (mayor’s 2030 goal).

Pipeline:

8,000 units under construction (40% in Dorchester/Allston).

Economic Drivers

Life Sciences: $5B+ invested since 2020 (Moderna, Vertex, Takeda).

Tech: 25% of office demand from AI/robotics firms.

Education: Harvard/MIT spin-offs lease 1.5M sq. ft. annually.

Challenges

Interest Rates: Debt costs at 6-7% slow transactions.

Climate Risk:

Seaport flood insurance up 30% (FEMA maps).

$2B resiliency plan underway (harbor barriers, elevated parks).

Affordability:

Office-to-resi conversions stalled by high costs ($400/sq. ft.).

Investment Opportunities

Life Sciences Clusters: Allston, Fenway, Cambridge.

Transit-Oriented Development:

Orient Heights (Blue Line).

Nubian Square (Fairmount Line).

Stadium-Adjacent Assets:

Suffolk Downs retail parcels.

Widett Circle industrial conversions.

Data Sources

Brokerage Reports: CBRE, JLL, Colliers (Q2 2024).

Public Data: BPDA, MassEcon, City of Boston.

NBA Speculation: Boston Globe, Boston Business Journal.